Improving Vaccinations for Young Children (IVY)
NCT04203277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2020-05-07
Summary
The IVY project focuses on improving combination 10 vaccine rates for Tennessee children through an educational and quality improvement intervention rolled out through a stepped-wedge cluster randomized trial.
Conditions
- Vaccination Refusal
Interventions
- OTHER
-
IVY
a combination of practice education and quality improvement interventions
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Sarah E Williams, MD, MPH · Vanderbilt University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2020-02-28
- Completion
- 2020-02-28
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers
NCT01091298 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
NCT00667602 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
NCT02285777 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life
NCT01214837 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants
NCT00757926 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Surveillance of Streptococcal Infections in Children in India
NCT00342199 ·Status: COMPLETED
-
Dose Confirmation Efficacy Study (V260-007)
NCT00092443 ·Status: COMPLETED ·Phase: PHASE3
-
Duration of IPV Priming and Antibody Decay
NCT03202719 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine
NCT02291263 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
NCT00548054 ·Status: UNKNOWN ·Phase: PHASE2
-
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
NCT01571505 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study With QIVc in Pediatric Subjects
NCT03932682 ·Status: COMPLETED ·Phase: PHASE3
-
Text Message Reminder-Recalls For Early Childhood Vaccination
NCT01199666 ·Status: COMPLETED ·Phase: NA
-
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
NCT00616421 ·Status: COMPLETED ·Phase: PHASE3
-
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
NCT06603090 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
NCT00474526 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation
NCT06860672 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Phase II Clinical Trial of the Inactivated Rotavirus Vaccine
NCT06080906 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
NCT01049035 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children
NCT02556996 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine Hesitancy: A Survey of Pediatric Clinicians
NCT01098825 ·Status: COMPLETED
-
Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
NCT02140762 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)
NCT01992536 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
NCT03691610 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.
NCT01682876 ·Status: COMPLETED ·Phase: PHASE3